Hypoparathyroidism

• EMA approval · 2025-07-15
  EMA Authorised: Natpar (parathyroid hormone) — Takeda Pharmaceuticals International AG Ireland Branch

  EU authorises Natpar (parathyroid hormone) for hypoparathyroidism. The decision includes conditional approval and orphan medicine designatio…

• CLINICAL_TRIALS approval · 2025-06-27
  Clinical Trial Update: Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism

  The expanded access program for Palopegteriparatide in hypoparathyroidism has been approved for marketing.

• EMA approval · 2025-06-20
  EMA Authorised: Yorvipath (palopegteriparatide) — Ascendis Pharma Bone Diseases A/S

  The EMA has authorised Yorvipath (palopegteriparatide) from Ascendis Pharma Bone Diseases A/S for the treatment of hypoparathyroidism and ha…

• FDA approval · 2019-02-21
  FDA Approved: CALCITRIOL — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approves a generic calcitriol product from Sun Pharmaceutical Industries under an original ANDA, enabling another generic calcitriol opt…

• FDA approval · 2018-11-21
  FDA Approved: CALCITRIOL — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved an original Abbreviated New Drug Application for calcitriol by Rising Pharma Holdings, Inc., providing a generic version of the…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2017-06-15
  FDA Approved: CALCIUM GLUCONATE — Original Application (Fresenius Kabi USA, LLC)

  The FDA approved Fresenius Kabi USA, LLC's calcium gluconate product under an original NDA.

• FDA approval · 2017-06-14
  FDA Approved: CALCITRIOL — Original Application (Amneal Pharmaceuticals LLC)

  FDA approved Amneal Pharmaceuticals' generic calcitriol (1,25-dihydroxyvitamin D3). The approval is an Original Application for this generic…

• FDA approval · 2013-05-24
  FDA Approved: CALCITRIOL — Original Application (BIONPHARMA INC.)

  FDA approved the original ANDA application for Calcitriol from BIONPHARMA INC., a generic version of the active vitamin D3 analog.